Bridgeway Capital Management, LLC Regenxbio Inc. Transaction History

Bridgeway Capital Management, LLC

  • $4.76 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
BUY
$18.08 - $24.55 $519,438 - $705,321
28,730 Added 16.91%
198,630 $3.76 Million
Q3 2022

Nov 14, 2022
BUY
$22.29 - $35.04 $557,250 - $876,000
25,000 Added 17.25%
169,900 $4.49 Million
Q2 2022

Aug 15, 2022
BUY
$19.35 - $35.04 $2.8 Million - $5.08 Million
144,900 New
144,900 $3.58 Million

Others Institutions Holding RGNX

# of Institutions
193
Shares Held
42.1M
Call Options Held
80.6K
Put Options Held
55.2K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $460M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Bridgeway Capital Management, LLC Portfolio

Follow Bridgeway Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email